These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 530497)

  • 21. Opiate-induced turning in rats after injection into the ventral tegmental area.
    Szewczak MR; Spoerlein MT
    Pharmacol Biochem Behav; 1986 Nov; 25(5):959-65. PubMed ID: 3538063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens.
    Vezina P; Kalivas PW; Stewart J
    Brain Res; 1987 Aug; 417(1):51-8. PubMed ID: 3040185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of morphine and haloperidol on the electrical activity of rat nigrostriatal neurons.
    Iwatsubo K; Clouet DH
    J Pharmacol Exp Ther; 1977 Aug; 202(2):429-36. PubMed ID: 886472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Motivational versus motor impairment after haloperidol injection or 6-OHDA lesions in the ventral tegmental area or substantia nigra in rats.
    Papp M; Bal A
    Physiol Behav; 1986; 38(6):773-9. PubMed ID: 3103150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphine differentially affects ventral tegmental and substantia nigra brain reward thresholds.
    Nazzaro JM; Seeger TF; Gardner EL
    Pharmacol Biochem Behav; 1981 Mar; 14(3):325-31. PubMed ID: 7232458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute motor effects of N-methyl-D-aspartic acid and kainic acid applied focally to mesencephalic dopamine cell body regions in the rat.
    Pycock CJ; Dawbarn D
    Neurosci Lett; 1980 May; 18(1):85-90. PubMed ID: 6763165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circling from intracranial morphine applied to the ventral tegmental area in rats.
    Holmes LJ; Bozarth MA; Wise RA
    Brain Res Bull; 1983 Sep; 11(3):295-8. PubMed ID: 6640359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of low doses of morphine on the activity of dopamine-containing cells and on behavior.
    Ostrowski NL; Hatfield CB; Caggiula AR
    Life Sci; 1982 Nov 15-22; 31(20-21):2347-50. PubMed ID: 7162350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat.
    Kalivas PW; Duffy P; Latimer LG
    J Pharmacol Exp Ther; 1987 Sep; 242(3):757-63. PubMed ID: 3498816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
    Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM
    Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of N-n-propylnorapomorphine enantiomers on single unit activity of substantia nigra pars compacta and ventral tegmental area dopamine neurons.
    Cox RF; Neumeyer JL; Waszczak BL
    J Pharmacol Exp Ther; 1988 Oct; 247(1):355-62. PubMed ID: 3171980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine.
    Stewart J; Vezina P
    Brain Res; 1989 Aug; 495(2):401-6. PubMed ID: 2670065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that physical dependence on morphine is mediated by the ventral midbrain.
    Baumeister AA; Anticich TG; Hebert G; Hawkins MF; Nagy M
    Neuropharmacology; 1989 Nov; 28(11):1151-7. PubMed ID: 2594160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.
    Schneider JS; Yuwiler A; Markham CH
    Brain Res; 1987 May; 411(1):144-50. PubMed ID: 2886180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B; Rothwell LA; Seabrook GR
    Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum.
    Cragg S; Rice ME; Greenfield SA
    J Neurophysiol; 1997 Feb; 77(2):863-73. PubMed ID: 9065855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra.
    French ED; Dillon K; Wu X
    Neuroreport; 1997 Feb; 8(3):649-52. PubMed ID: 9106740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facilitation of sexual behaviors in the male rat associated with intra-VTA injections of opiates.
    Mitchell JB; Stewart J
    Pharmacol Biochem Behav; 1990 Mar; 35(3):643-50. PubMed ID: 1971113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kynurenate blocks the acute effects of haloperidol on midbrain dopamine neurons recorded in vivo.
    Tung CS; Grenhoff J; Svensson TH
    J Neural Transm Gen Sect; 1991; 84(1-2):53-64. PubMed ID: 2054150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y; Hashimoto K; Watanabe KI; Ashby CR
    Synapse; 2001 May; 40(2):102-12. PubMed ID: 11252021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.